A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

For decades, scientists have searched for a way to outsmart Lyme disease, a stealthy infection that affects nearly half a million people each year in the U.S. Now, a breakthrough may be within reach.

In the realm of Lyme disease research, one antibiotic emerged as being highly effective for treatment of acute infection, and ...

Piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less than the effective dose of doxycycline, the current gold standard treatment. At ...

Lyme disease, a disease transmitted when deer ticks feed on infected animals like deer and rodents, and then bite humans, impacts nearly half a million individuals in the U.S. annually.

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its ...

In the evening of April 22, Valneva will attend the Vaccine Industry Excellence Awards ceremony, where it is a finalist for the Best Biotech Award and Best Prophylactic Vaccine Award for VLA15, the ...

One vaccine to note is Pfizer and Valneva’s Lyme borreliosis vaccine candidate, VLA15. Annually, Lyme disease is responsible for over 475,000 infections in the US and nearly 130,000 infections in ...

The Massachusetts Department of Public Health reports the majority of tick-borne diseases occur between June and August, but ...

Revenues from our growing commercial business help fuel the continued advancement of our vaccine pipeline. This includes the only Lyme disease vaccine candidate in advanced clinical development ...